510(k) Report

510(k) · Cleared

Cleared

Acon Bzo One Step Benzodiazepines Test Strip; Acon Bzo One Step Benzodiazepines Test Device

K012300510(k) TraditionalCleared Sep 17, 200159-day reviewClass II21 CFR 862.3170

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ACON Laboratories, Inc. · JXM Enzyme Immunoassay, Benzodiazepine

Cleared on Sep 17, 2001 as substantially equivalent to K991079 (Princeton BioMeditech Corp., 1999) after a 59-day review. Its family tree reaches back 1 generation to 1999. 92 later devices descend from it.

Decided
Sep 17, 2001
Review
59 days
Class
Class II
Product code
JXM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K991079 (1999). 92 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2004: 3 descendants cleared2003: 2 descendants cleared2006: 3 descendants cleared2013: 4 descendants cleared2005: 1 descendant cleared2009: 1 descendant cleared2014: 4 descendants cleared2016: 9 descendants cleared2015: 9 descendants cleared2011: 1 descendant cleared2012: 1 descendant cleared2018: 9 descendants cleared2020: 4 descendants cleared2023: 7 descendants cleared2019: 6 descendants cleared2017: 2 descendants cleared2025: 7 descendants cleared2021: 3 descendants cleared2024: 9 descendants cleared2022: 3 descendants cleared2026: 4 descendants clearedK991079 · Accusign Bzo, Biosign Bzo, Status Bzo · Princeton BioMeditech Corp. · 19991995200020052010201520202025
Descendants, by generation 1 generation forward: 5 descendants2 generations forward: 3 descendants3 generations forward: 4 descendants4 generations forward: 7 descendants5 generations forward: 23 descendants6 generations forward: 20 descendants7 generations forward: 16 descendants8 generations forward: 9 descendants9 generations forward: 5 descendants K991079 · Accusign Bzo, Biosign Bzo, Status Bzo · Princeton BioMeditech Corp. · 19990+5
  1. Root · 1 generation backK991079 Accusign Bzo, Biosign Bzo, Status BzoPrinceton BioMeditech Corp. · 1999
  2. This deviceK012300 Acon Bzo One Step Benzodiazepines Test Strip; Acon Bzo One Step…ACON Laboratories, Inc. · 2001
  3. Descendant · cites it directly · 86 of its ownK023946 Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step…ACON Laboratories, Inc. · 2003
  4. Descendant · 2 generations on · 83 of its ownK031759 Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon…ACON Laboratories, Inc. · 2003 · Recalled
  5. Descendant · 3 generations on · 80 of its ownK061718 Innovacon Spectrum II Test CardInnovacon, Inc. · 2006 · Recalled
  6. Descendant · 4 generations on · 55 of its ownK122809 Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech · 2013
  7. Descendant · 5 generations on · 16 of its ownK140748 One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test…Co-Innovation Biotech Co., Ltd. · 2014

Showing 5 of 92 descendants. See all descendants

Descendants cleared per year

2003: 22004: 32005: 12006: 32009: 12011: 12012: 12013: 42014: 42015: 92016: 92017: 22018: 92019: 62020: 42021: 32022: 32023: 72024: 92025: 72026: 4
2003high 9 (2015) · low 0 (2007)2026

Most influential descendants

Showing 5 of 92 · See all
  • K023946Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step Multi-Drug…ACON Laboratories, Inc. · 2003 · cites it directly86descendants
  • K031759Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon Spectrum Multi-Drug…ACON Laboratories, Inc. · 2003 · 2 generations on83descendants
  • K061718Innovacon Spectrum II Test CardInnovacon, Inc. · 2006 · 3 generations on80descendants
  • K122809Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech · 2013 · 4 generations on55descendants
  • K140748One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test DipcardCo-Innovation Biotech Co., Ltd. · 2014 · 5 generations on16descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K991079Accusign Bzo, Biosign Bzo, Status BzoPrinceton BioMeditech Corp.1999—
0 (this device)K012300Acon Bzo One Step Benzodiazepines Test Strip; Acon Bzo One Step…ACON Laboratories, Inc.2001—
+1K023946Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step Multi-Drug…ACON Laboratories, Inc.2003—
+2K031759Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon Spectrum…ACON Laboratories, Inc.20031
+3K061718Innovacon Spectrum II Test CardInnovacon, Inc.20066
+4K122809Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech2013—
+5K140748One Step Single/Multi-Drug Test Cup, One Step Single/Multi-Drug Test DipcardCo-Innovation Biotech Co., Ltd.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200320
200430
200510
200630
200910
201110
201210
201340
201440
201590
201690
201720
201890
201960
202040
202130
202230
202370
202490
202570
202640
FIG. 1 — Lineage of K012300, 1999–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JXM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JXM device

  1. #1 K243498 Alinity c Benzodiazepines Reagent Kitscore 8.8 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K991079Accusign Bzo, Biosign Bzo, Status Bzo
Summary page 2
…hat proper volume of specimen has been added and membrane wicking has occurred, Predicéte Device: LifeSign Status DS™ BZO One-Step Benzodiazepines Test 510(k) Number: K991079 Comparison to a Predicatc Device: A comparison of the features of the ACON BZO One Step Benzodiazepines Test Strip and ACON BZ…
Princeton BioMeditech Corp.1999—

What descends from it? (92)

See all 92

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K023946Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step Multi-Drug…ACON Laboratories, Inc.200386
K041685Acon Multi-Clin Drug Screen Test DeviceACON Laboratories, Inc.20041
K121065Polymed Therapeutics Fastep Dipstick Drugs of Abuse Screen Device and Dipcard Drugs of…Polymed Therapeutics, Inc.20130
K052197First Sign Drug of Abuse Urine Screening TestW.H.P.M., Inc.20060
K041743Acon Tri-Fect Drug Screen Test DeviceACON Laboratories, Inc.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K023946 (ACON Laboratories, Inc., 2003) has gone furthest, with 86 descendants of its own.

How does its category compare?

All JXM devices

JXM Enzyme Immunoassay, Benzodiazepine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JXM

1in 2024

2010: 12011: 12012: 12015: 22016: 22017: 22018: 12019: 12022: 12024: 1
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JXM

Too few JXM 510(k)s in any year since 2007 to give a median.

Recalls per year · JXM

79in 2015

2015: 79
2007high 79 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JXM

6in 2025

2008: 32009: 12010: 32011: 32012: 12013: 32014: 32015: 52016: 22017: 42018: 42019: 32021: 12023: 52024: 62025: 6
2007high 6 (2024) · low 0 (2007)2025

MAUDE reports naming product code JXM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—03
20090—01
20101—03
20111—03
20121—01
20130—03
20140—03
20152—795
20162—02
20172—04
20181—04
20191—03
20200—00
20210—01
20221—00
20230—05
20241—06
20250—06
20260—0—

What is it indicated for?

The ACON BZO One Step Benzodiazepines Test Strip and ACON BZO One Step Benzodiazepines Test Device are rapid chromatographic immunoassays for the qualitative detection of Benzodiazepines in human urine at a cut-off concentration of 300 ng/mL set relative to oxazepam, a major metabolite of benzodiazepines. They are intended for healthcare professionals including professionals at point of care sites.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K012300: Acon Bzo One Step Benzodiazepines Test Strip; Acon Bzo One Step Benzodiazepines Test Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K012300

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026